Is AXLA or SCHD a better dividend investment in 2026?

AXLA currently yields 43.67% with a 5% 5-year dividend growth rate. SCHD yields 3.44% with 13.05% growth. The better choice depends on your goal: AXLA offers higher current income.

What is the dividend yield difference between AXLA and SCHD?

AXLA has a forward dividend yield of 43.67% ($2.00/share annually). SCHD yields 3.44% ($1.06/share annually). The yield gap is 40.23 percentage points.

Home › Compare › AXLA vs SCHD

AXLA vs SCHD: Dividend Comparison 2026

AXLA yields 43.67% · SCHD yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AXLA wins by $253.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

AXLA

● Live price

43.67%

Share price

$4.58

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$282.6K

Annual income

$51,335.69

Full AXLA calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.44%

Share price

$30.68

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$422.61

Full SCHD calculator →

Portfolio growth — AXLA vs SCHD

📍 AXLA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AXLA	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AXLA + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AXLA pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AXLA

Annual income on $10K today (after 15% tax)

$3,711.79/yr

After 10yr DRIP, annual income (after tax)

$43,635.34/yr

SCHD

Annual income on $10K today (after 15% tax)

$292.49/yr

After 10yr DRIP, annual income (after tax)

$359.22/yr

At 15% tax rate, AXLA beats the other by $43,276.12/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AXLA + SCHD for your $10,000?

AXLA: 50%SCHD: 50%

100% SCHD50/50100% AXLA

Portfolio after 10yr

$155.8K

Annual income

$25,879.14/yr

Blended yield

16.61%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on AXLA right now

AXLA

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$60.00

+1210.0% upside vs current

Range: $60.00 — $60.00

Altman Z

-80.1

Piotroski

3/9

SCHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AXLA buys

SCHD buys

No recent congressional trades found for AXLA or SCHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAXLASCHD

Forward yield	43.67% ✓	3.44%
Annual dividend / share	$2.00 ✓	$1.06
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$282.6K ✓	$29.0K
Annual income after 10y	$51,335.69 ✓	$422.61
Total dividends collected	$217.9K ✓	$3.9K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: AXLA vs SCHD ($10,000, DRIP)

Year	AXLA Portfolio	AXLA Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1← crossover	$15,067	$4,366.81	$11,224	$344.10	+$3.8K → AXLA
2	$22,270	$6,148.97	$12,567	$354.98	+$9.7K → AXLA
3	$32,324	$8,494.27	$14,038	$365.30	+$18.3K → AXLA
4	$46,108	$11,522.15	$15,648	$375.06	+$30.5K → AXLA
5	$64,697	$15,360.67	$17,410	$384.27	+$47.3K → AXLA
6	$89,369	$20,143.18	$19,335	$392.95	+$70.0K → AXLA
7	$121,629	$26,004.42	$21,437	$401.10	+$100.2K → AXLA
8	$163,219	$33,076.14	$23,733	$408.75	+$139.5K → AXLA
9	$216,127	$41,482.53	$26,237	$415.91	+$189.9K → AXLA
10	$282,592	$51,335.69	$28,968	$422.61	+$253.6K → AXLA

AXLA vs SCHD: Complete Analysis 2026

AXLA — Stock

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Full AXLA Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this AXLA vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AXLA vs JEPI AXLA vs O AXLA vs KO AXLA vs MAIN AXLA vs VYM AXLA vs DGRO AXLA vs VIG AXLA vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.